L3VLUP
ProSign in

RMD in the 13F filings

Resmed Inc · CUSIP 761152107

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Mar 2025
the date the book describes
Filed
27 Aug 2025
latest of these filings; the earliest 12 May 2025
Managers listing it
9
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q4 2024 and Q1 2025; 5 listed it in both
Shares listed
3,776,642
combined, among listed positions
Reported value
$844m
combined, at the quarter end

Among the 95 comparable managers: 7 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing RMD in Q1 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

9 of 9 holders

ActionFiling
Invesco Ltd2,294,031$514m0.10%Trimmed-30,97812 May 2025 (the filing on sec.gov)
Marshall Wace LLP556,432$125m0.16%Addedn.a.15 May 2025 (the filing on sec.gov)
AQR Capital Management LLC402,416$88m0.09%Trimmed-222,63815 May 2025 (the filing on sec.gov)
Squarepoint Ops LLC234,832$53m0.06%Addedn.a.27 Aug 2025 (the filing on sec.gov)
Man Group PLC134,925$30m0.08%Added+8315 May 2025 (the filing on sec.gov)
Bridgewater Associates LP119,331$27m0.12%Added+32,06014 May 2025 (the filing on sec.gov)
Element Capital Management LLC12,295$2.8m0.68%Newnew13 May 2025 (the filing on sec.gov)
PDT Partners LLC11,835$2.6m0.19%Added+30015 May 2025 (the filing on sec.gov)
Quantbot Technologies LP10,545$2.4m0.08%Addedn.a.13 May 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2024 to Q1 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
11 in Q3 2024 to 13 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
RMD by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20137$351mn.a.n.a.
Q3 20135$464mn.a.n.a.
Q4 20137$486mn.a.n.a.
Q1 20148$648mn.a.n.a.
Q2 20145$738mn.a.n.a.
Q3 20145$502mn.a.n.a.
Q4 20146$1.0bnn.a.n.a.
Q1 20156$1.2bnn.a.n.a.
Q2 20156$688mn.a.n.a.
Q3 20159$661mn.a.n.a.
Q4 20159$902mn.a.n.a.
Q1 201617$954mn.a.n.a.
Q2 201611$1.0bnn.a.n.a.
Q3 201614$1.1bnn.a.n.a.
Q4 20164$1.0bnn.a.n.a.
Q1 20175$1.1bnn.a.n.a.
Q2 20176$1.6bnn.a.n.a.
Q3 20174$1.8bnn.a.n.a.
Q4 20177$2.1bnn.a.n.a.
Q1 20189$2.6bnn.a.n.a.
Q2 201815$2.7bnn.a.n.a.
Q3 201816$2.7bnn.a.n.a.
Q4 201815$2.5bnn.a.n.a.
Q1 20199$2.0bnn.a.n.a.
Q2 201910$2.5bnn.a.n.a.
Q3 201913$2.7bnn.a.n.a.
Q4 201910$3.1bnn.a.n.a.
Q1 202014$2.9bnn.a.n.a.
Q2 20208$3.7bnn.a.n.a.
Q3 202015$3.0bnn.a.n.a.
Q4 20209$3.7bnn.a.n.a.
Q1 202110$2.9bnn.a.n.a.
Q2 202112$3.7bnn.a.n.a.
Q3 202115$4.2bnn.a.n.a.
Q4 202118$3.5bnn.a.n.a.
Q1 202210$4.0bnn.a.n.a.
Q2 202211$3.4bnn.a.n.a.
Q3 202213$3.9bnn.a.n.a.
Q4 202219$3.7bnn.a.n.a.
Q1 202321$3.9bnn.a.n.a.
Q2 202326$3.7bnn.a.n.a.
Q3 202317$1.9bnn.a.n.a.
Q4 202310$1.0bn312
Q1 20248$513m45
Q2 20249$574m56
Q3 202411$1.0bn65
Q4 20249$914m55
Q1 20259$844m73
Q2 20257$810m44
Q3 20258$1.1bn62
Q4 202511$1.0bn1516
Q1 20269$919m1615
Q2 202613$1.1bn2111

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

RMD and LLY →RMD and JNJ →RMD and VRTX →Choose a stock to compare with RMD →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own RMD, latest filings →Back to the 13F Explorer →